|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Dopamine D2 receptor polymorphisms and susceptibility to alcohol dependence in Indian males:a preliminary study显示文摘 | Prasad P Ambekar A Vaswani M | | 0，，02： | 1 |
| 2 | Detection of aqueous mercuric ion with a structurally simple 8-hydroxyquinoline derived ON- OFF fluoroseusor显示文摘 | Vaswani K G Kerinen M D | 2009 | Inorg Chem2009，48，13： | 1 |
| 3 | Exciton analysis in 2D electronic spectroscopy显示文摘 | CHO M VASWANI M BRIXNER T | 2005 | The Journal of Physical Chemistry B2005，109，10： | 1 |
| 4 | A memory of errors in sensorimotor learning 显示文摘 | Herzfeld D J Vaswani P A Marko M K | 2014 | Science2014，345，6202： | 1 |
| 5 | Role of selectivem tonin ttuptabe inhibition in psychiatric disorders:a comprehenisve review显示文摘 | Vaswani M Linda FK Ramesh S | 2003 | Prag Neure- psychopharmacol Biol Psychiatry2003，27，1： | 1 |
| 6 | Flunarizine as add-on therapy in refractory epilepsy:An open trial显示文摘 | Jain S Vaswani M | 1996 | Journal of Epilepsy1996，9，1： | 1 |
| 7 | Role of selective serotonin reuptake inhibitors in psychiatric Disorders:a comprehensive review显示文摘 | Vaswani M Linda F K Ramesh S | 2003 | Progress in Neuro-Psychopharmacology and Biological Psychiatry2003，27，： | 1 |
| 8 | Sonography case of the day显示文摘 | VASWANI K VITELLAS K M BENNKTT W F | 2000 | AJR Am J Roentgenol2000，175，： | 1 |
| 9 | Role of selective serotonin reuptake inhibitors in psychiatric disorders:a comprehensive review显示文摘 | Vaswani M Linda FK Ramesh S | 2003 | Prog Neuropsychopharmacol Biol Psychiatry2003，27，1： | 1 |
| 10 | Normal appendix, appendicitis, and complications: CT evaluation-a practical approach and challenges for diagnostic radiologists显示文摘 | Vaswani K K Seth S K Vitellas K M | 2002 | Radiologist2002，9，1： | 1 |
| 11 | Role of selective serotonin reuptake inhibition in psychiatric disorders: a comprehenisve review显示文摘 | VASWANI M LINDA FK RAMESH S | 2003 | Prog Neuropsychopharmacol Biol Psychiatry2003，27，1： | 1 |
| 12 | Porous metals from colloidal templates显示文摘 | Kulinowski K M Jiang P Vaswani H Colvin V L | | 0，，11： | 1 |
| 13 | Role of selective serotonin reuptake inhibitors in psychiatric disorders:a comprehensive review显示文摘 | Vaswani M Linda FK Ramesh S | 2003 | Prog Neuropsychopharmacol Biol Psychiatry2003，27，1： | 1 |
| 14 | Porous metals from colloidal templates显示文摘 | Kulinowski K M Jiang P Vaswani H | 2000 | Adv Mater2000，12，： | 1 |
| 15 | EZH2 Inhibitor Efficacy in Non-Hodgkin’s Lymphoma Does Not Require Suppression of H3K27 Monomethylation显示文摘 | William D. Bradley Shilpi Arora Jennifer Busby Srividya Balasubramanian Victor S. Gehling Christopher G. Nasveschuk Rishi G. Vaswani Chih-Chi Yuan Charlie Hatton Feng Zhao Kaylyn E. Williamson Priyadarshini Iyer Jacqui Méndez Robert Campbell Nico Cantone | 2014 | Chemistry & Biology2014，，11： | 1 |
| 16 | Light treatment for seasonal Winter depression in African-American vs Caucasian outpatients显示文摘AIM: To compare adherence, response, and remission with light treatment in African-American and Caucasian patients with Seasonal Affective Disorder.METHODS: Seventy-eight study participants, agerange 18-64(51 African-Americans and 27 Caucasians)recruited from the Greater Baltimore Metropolitan area, with diagnoses of recurrent mood disorder with seasonal pattern, and confirmed by a Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders-Ⅳ, were enrolled in an open label study of daily bright light treatment. The trial lasted6 wk with flexible dosing of light starting with 10000 lux bright light for 60 min daily in the morning. At the end of six weeks there were 65 completers. Three patients had Bipolar Ⅱ disorder and the remainder had Major depressive disorder. Outcome measures were remission(score ≤ 8) and response(50% reduction)in symptoms on the Structured Interview Guide for the Hamilton Rating Scale for Depression(SIGH-SAD)as well as symptomatic improvement on SIGH-SAD and Beck Depression Inventory-Ⅱ. Adherence was measured using participant daily log. Participant groups were compared using t-tests, chi square, linear and logistic regressions. RESULTS: The study did not find any significant group difference between African-Americans and their Caucasian counterparts in adherence with light treatment as well as in symptomatic improvement.While symptomatic improvement and rate of treatment response were not different between the two groups,African-Americans, after adjustment for age, gender and adherence, achieved a significantly lower remission rate(African-Americans 46.3%; Caucasians 75%; P =0.02).CONCLUSION: This is the first study of light treatment in African-Americans, continuing our previous work reporting a similar frequency but a lower awareness of SAD and its treatment in African-Americans. Similar rates of adherence, symptomatic improvement and treatment response suggest that light treatment is a feasible, acceptable, and beneficial treatment for SAD in African-American patients. These results should lead to intensifying education initiatives to increase awareness of SAD and its treatment in African-American communities to increased SAD treatment engagement.In African-American vs Caucasian SAD patients a remission gap was identified, as reported before with antidepressant medications for non-seasonal depression, demanding sustained efforts to investigate and then address its causes. | Hyacinth N Uzoma Gloria M Reeves Patricia Langenberg Baharak Khabazghazvini Theodora G Balis Mary A Johnson Aamar Sleemi Debra A Scrandis Sarah A Zimmerman Dipika Vaswani Gagan Virk Nijjar Johanna Cabassa Manana Lapidus Kelly J Rohan Teodor T Postolache | 2015 | World Journal of Psychiatry2015，5，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员